115 related articles for article (PubMed ID: 15680419)
1. Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2.
Hu YW; Rocheleau L; Larke B; Chui L; Lee B; Ma M; Liu S; Omlin T; Pelchat M; Brown EG
Virology; 2005 Feb; 332(2):538-49. PubMed ID: 15680419
[TBL] [Abstract][Full Text] [Related]
2. Evolutionary study of hepatitis C virus envelope genes during primary infection.
Chen S; Wang YM
Chin Med J (Engl); 2007 Dec; 120(24):2174-80. PubMed ID: 18167197
[TBL] [Abstract][Full Text] [Related]
3. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment.
Penin F; Combet C; Germanidis G; Frainais PO; Deléage G; Pawlotsky JM
J Virol; 2001 Jun; 75(12):5703-10. PubMed ID: 11356980
[TBL] [Abstract][Full Text] [Related]
4. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
[TBL] [Abstract][Full Text] [Related]
5. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
[TBL] [Abstract][Full Text] [Related]
6. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees.
Zhou YH; Sugitani M; Esumi M
Arch Virol; 2002 Oct; 147(10):1955-62. PubMed ID: 12376756
[TBL] [Abstract][Full Text] [Related]
7. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
[TBL] [Abstract][Full Text] [Related]
8. Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene.
Sominskaya I; Alekseeva E; Skrastina D; Mokhonov V; Starodubova E; Jansons J; Levi M; Prilipov A; Kozlovska T; Smirnov V; Pumpens P; Isaguliants MG
Mol Immunol; 2006 May; 43(12):1941-52. PubMed ID: 16442623
[TBL] [Abstract][Full Text] [Related]
9. Variant analysis and immunogenicity prediction of envelope gene of HCV strains from China.
Cai Q; Zhang X; Tian L; Yuan M; Jin G; Lu Z
J Med Virol; 2002 Aug; 67(4):490-500. PubMed ID: 12115994
[TBL] [Abstract][Full Text] [Related]
10. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody.
Taniguchi S; Okamoto H; Sakamoto M; Kojima M; Tsuda F; Tanaka T; Munekata E; Muchmore EE; Peterson DA; Mishiro S
Virology; 1993 Jul; 195(1):297-301. PubMed ID: 7686313
[TBL] [Abstract][Full Text] [Related]
11. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
[TBL] [Abstract][Full Text] [Related]
12. [Sequence diversity of genotype II/1b hepatitis C virus (HCV) HVR1 of 46 patients in Beijing areas].
Zhao J; Cheng Y; Zhang H
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):88-90. PubMed ID: 10488415
[TBL] [Abstract][Full Text] [Related]
13. [Cloning and sequencing of cDNA of E2/NS1 gene of hepatitis C virus].
Shen D; Lu H; Li M; He L; Shang D; Ma X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):227-31. PubMed ID: 15617335
[TBL] [Abstract][Full Text] [Related]
14. Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection.
Higashi K; Tsukiyama-Kohara K; Tanaka T; Tanaka E; Kiyosawa K; Kohara M
Arch Virol; 2005 May; 150(5):883-98. PubMed ID: 15662481
[TBL] [Abstract][Full Text] [Related]
15. Conformational epitopes detected by cross-reactive antibodies to envelope 2 glycoprotein of the hepatitis C virus.
Nakano I; Fukuda Y; Katano Y; Hayakawa T
J Infect Dis; 1999 Oct; 180(4):1328-33. PubMed ID: 10479166
[TBL] [Abstract][Full Text] [Related]
16. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
17. Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits.
Shang D; Zhai W; Allain JP
Virology; 1999 Jun; 258(2):396-405. PubMed ID: 10366577
[TBL] [Abstract][Full Text] [Related]
18. Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2.
Yi M; Nakamoto Y; Kaneko S; Yamashita T; Murakami S
Virology; 1997 Apr; 231(1):119-29. PubMed ID: 9143310
[TBL] [Abstract][Full Text] [Related]
19. Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence.
Moorman JP; Joo M; Hahn YS
Arch Immunol Ther Exp (Warsz); 2001; 49(3):189-94. PubMed ID: 11478392
[TBL] [Abstract][Full Text] [Related]
20. Differences in hypervariable region 1 quasispecies between immune complexed and non-immune complexed hepatitis C virus particles.
Korenaga M; Hino K; Okazaki M; Okuda M; Okita K
Biochem Biophys Res Commun; 1997 Nov; 240(3):677-82. PubMed ID: 9398625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
